Work

Src inhibition through a phase II study of 5-fluorouracil, oxaliplatin, plus dasatinib (FOLFOX-D) in first-line metastatic pancreatic adenocarcinoma.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.3_suppl.319

Authors: Thomas J. George, Alison Marguerite Ivey, Karen Colleen Daily, Long H. Dang, Scott Watson, Renee Granicz, Kevin Tormes, Xiaomin Lu, Chen Liu, Carmen Joseph Allegra, Kevin Behrns, Steven J. Hughes, Olorunseun Olatunji Ogunwobi, Jose Gilberto Trevino

Institution: University of Florida

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590007779

Cites:

Cited by:

Related to: 10